The European Commission publishes its preliminary report on its competition enquiry into the pharmaceutical sector

The relationship between competition law and intellectual property rights has been the subject of much debate during the European Commission’s on-going pharmaceutical sector enquiry. In particular, there has been some concern that competition law could encroach on the complex rules governing patents and innovation. With the recent publication of a submission made by the European Patent Office (EPO) to the Commission in connection with its enquiry, this debate has once again come to the fore. The EPO’s submission queries several aspects of the Commission’s preliminary findings and warns against upsetting some of the principles and procedures of patentability. The Commission published its preliminary report on its competition enquiry into the pharmaceutical sector on 28 November 2008. The

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • Van Bael & Bellis (Brussels)

Quotation

Martin Favart, The European Commission publishes its preliminary report on its competition enquiry into the pharmaceutical sector, 28 November 2008, e-Competitions Bulletin November 2008, Art. N° 44970

Visites 112

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues